NeueHealth Statistics
Total Valuation
NeueHealth has a market cap or net worth of $50.01 million. The enterprise value is $3.64 million.
| Market Cap | 50.01M |
| Enterprise Value | 3.64M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NeueHealth has 8.22 million shares outstanding. The number of shares has increased by 2.34% in one year.
| Shares Outstanding | 8.22M |
| Shares Change (YoY) | +2.34% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 5.48% |
| Owned by Institutions (%) | 63.61% |
| Float | 3.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.56 |
| PS Ratio | 0.05 |
| Forward PS | 0.06 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.77
| Current Ratio | 0.77 |
| Quick Ratio | 0.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -47.50% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $882,865 |
| Profits Per Employee | -$832,438 |
| Employee Count | 1,252 |
| Asset Turnover | 0.50 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.34% in the last 52 weeks. The beta is 0.86, so NeueHealth's price volatility has been lower than the market average.
| Beta (1Y) | 0.86 |
| 52-Week Price Change | -56.34% |
| 50-Day Moving Average | 6.44 |
| 200-Day Moving Average | 7.78 |
| Relative Strength Index (RSI) | 43.51 |
| Average Volume (30 Days) | 12,219 |
Short Selling Information
The latest short interest is 42,198, so 0.51% of the outstanding shares have been sold short.
| Short Interest | 42,198 |
| Short Previous Month | 40,560 |
| Short % of Shares Out | 0.51% |
| Short % of Float | 1.26% |
| Short Ratio (days to cover) | 4.22 |
Income Statement
In the last 12 months, NeueHealth had revenue of $1.11 billion and -$1.04 billion in losses. Loss per share was -$130.59.
| Revenue | 1.11B |
| Gross Profit | 172.01M |
| Operating Income | -555.23M |
| Pretax Income | -994.38M |
| Net Income | -1.04B |
| EBITDA | -942.20M |
| EBIT | -961.04M |
| Loss Per Share | -$130.59 |
Balance Sheet
The company has $112.76 million in cash and $66.40 million in debt, giving a net cash position of $46.36 million or $5.64 per share.
| Cash & Cash Equivalents | 112.76M |
| Total Debt | 66.40M |
| Net Cash | 46.36M |
| Net Cash Per Share | $5.64 |
| Equity / Book Value | -1.26B |
| Book Value Per Share | -153.35 |
| Working Capital | -285.09M |
Cash Flow
In the last 12 months, operating cash flow was -$2.16 billion and capital expenditures -$1.10 million, giving a free cash flow of -$2.16 billion.
| Operating Cash Flow | -2.16B |
| Capital Expenditures | -1.10M |
| Free Cash Flow | -2.16B |
| FCF Per Share | -$267.53 |
Margins
Gross margin is 15.56%, with operating and profit margins of -50.23% and -94.29%.
| Gross Margin | 15.56% |
| Operating Margin | -50.23% |
| Pretax Margin | -89.96% |
| Profit Margin | -94.29% |
| EBITDA Margin | -85.24% |
| EBIT Margin | -86.94% |
| FCF Margin | -195.53% |
Dividends & Yields
NeueHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.34% |
| Shareholder Yield | -2.34% |
| Earnings Yield | -2,084.21% |
| FCF Yield | -4,322.22% |
Analyst Forecast
The average price target for NeueHealth is $8.00, which is 33.56% higher than the current price. The consensus rating is "Hold".
| Price Target | $8.00 |
| Price Target Difference | 33.56% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 22, 2023. It was a reverse split with a ratio of 1:80.
| Last Split Date | May 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:80 |
Scores
NeueHealth has an Altman Z-Score of -7.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.63 |
| Piotroski F-Score | 2 |